Hospital Universitario Virgen del Rocío is the name of the complex of hospitals located in the center of Sevilla, and one of the most important hospitals in the South of Spain, being the biggest hospital in the region. It is managed by the public company "Servicio Andaluz de Salud".

There are 1,251 beds in Hospital Universitario Virgen del Rocío.

During the past decade, Hospital Universitario Virgen del Rocío conducted 777 clinical trials. In the 10-year time frame, 777 clinical trials started and 244 clinical trials were completed, i.e. on average, 31.4% percent of trials that started reached the finish line to date. In the past 5 years, 397 clinical trials started and 183 clinical trials were completed. i.e. 46.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario Virgen del Rocío" #1 sponsor was "Fundación Pública Andaluza para la gestión de la Investigación en Sevilla" with 46 trials, followed by "PETHEMA Foundation" with 46 trials sponsored, "Pfizer" with 39 trials sponsored, "Celgene" with 38 trials sponsored and "Gilead Sciences" with 38 trials sponsored. Other sponsors include 820 different institutions and companies that sponsored additional 354 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Virgen del Rocío" #1 collaborator was "Pfizer" with 16 trials as a collaborator, "AstraZeneca" with 15 trials as a collaborator, "Hoffmann-La Roche" with 13 trials as a collaborator, "Merck Sharp & Dohme LLC" with 13 trials as a collaborator and "Bristol-Myers Squibb" with 12 trials as a collaborator. Other collaborators include 488 different institutions and companies that were collaborators in the rest 316 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario Virgen del Rocío" are "Breast Cancer" (43 trials), "Multiple Myeloma" (28 trials), "HIV Infections" (21 trials), "Myelodysplastic Syndromes" (15 trials) and "Cystic Fibrosis" (14 trials). Many other conditions were trialed in "Hospital Universitario Virgen del Rocío" in a lesser frequency.

Most popular intervention types in "Hospital Universitario Virgen del Rocío" are "Drug" (801 trials), "Other" (94 trials), "Biological" (59 trials), "Procedure" (36 trials) and "Device" (32 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (172 trials), "Dexamethasone" (31 trials), "Carboplatin" (30 trials), "Gemcitabine" (23 trials) and "Docetaxel" (22 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario Virgen del Rocío" are 921 trials for "All" genders, 64 trials for "Female" genders and 39 trials for "Male" genders.

Currently, there are 414 active trials in "Hospital Universitario Virgen del Rocío". 7 are not yet recruiting, 255 are recruiting, 148 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 445 completed trials in Hospital Universitario Virgen del Rocío, 3 suspended trials, and 105 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario Virgen del Rocío, 124 "Phase 1" clinical trials were conducted, 330 "Phase 2" clinical trials and 392 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 63 trials, and there were also 45 trials that are defined as “Not Applicable".

Hospital Universitario Virgen del Rocío has several departments that took part in Clinical trials: "Hospital Universitario Virgen del Rocio; Servicio de Hematologia" - 22 trials, "Hospital Universitario Virgen del Rocio; Servicio de Oncologia" - 42 trials, "Hospital Virgen del Rocío; Servicio de Neurología" - 5 trials, "Hospital Universitario Virgen del Rocio; Servicio de Neumologia" - 2 trials